CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to combat antimicrobial resistance by developing a rapid and cost-effective testing technology for antibiotic susceptibility. The Nanosynex system provides results in as little as two hours, enabling personalized treatment and reducing hospital stays, thereby addressing a critical healthcare challenge…
Antimicrobial Resistance (AMR), is the ability of microorganisms to resist to antibiotics treatment, contributes to 700,000 deaths a year (25,000 deaths in Europe).
Besides, The financial implications of AMR proliferation are devastating for the global healthcare system.
The current implementation of antimicrobial stewardship programs in hospitals has not been enough to mitigate the overuse and misuse of antibiotics.
Current AST (Antimicrobial Susceptibility Testing) diagnostic methods are highl…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
